Now in its 12th year, the World Drug Manufacturing Summit provides the key tools to overcome the biggest threats facing pharma manufacturers today.
World Drug Manufacturing 2013 focuses on achieving process and manufacturing excellence, process re-engineering, six sigma tools to reduce variability, with specific case studies on continuous improvement, successful QbD implementations, real time data collection, analysis, knowledge management and much more.
Key themes for 2013 include:
Drug manufacturers want to understand the real benefits of becoming a process flow organisations as the basis for manufacturing excellence vs. the functional silo organisations which have been a barrier to continuous improvement.
The need to change mindsets, improve manufacturing strategies, reduce costs and satisfy regulators as the industry comes under fire from price pressures and healthcare reform, is key at this time. The WDM summit provides in-depth answers, insights and case studies from industry leaders.
If you have any questions about this upcoming programme, or would like to speak or propose a paper at WDM 2013 please contact Dora Walsh on +44 (0) 20 7202 7695 or at email@example.com